R Sanders Williams Amgen Inc (AMGN) insider trading activity

R Sanders Williams is Director of AMGEN INC. Currently has a direct ownership of 6,240 shares of AMGN, which is worth approximately $1.75 Million. The most recent transaction as insider was on May 19, 2023, when has been sold 939 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.24K

0% 3M change

0% 12M change

Total Value Held $1.75 Million

R Sanders Williams Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 19 2023	BUY Grant, award, or other acquisition	-	939 Added 13.08%	6,240 Common Stock
Aug 22 2022	SELL Open market or private sale	$49,992 $249.96 p/Share	200 Reduced 3.64%	5,301 Common Stock
May 23 2022	SELL Open market or private sale	$150,000 $250.0 p/Share	600 Reduced 9.83%	5,501 Common Stock
May 17 2022	BUY Grant, award, or other acquisition	-	855 Added 12.29%	6,101 Common Stock
May 18 2021	BUY Grant, award, or other acquisition	-	837 Added 13.76%	5,246 Common Stock
May 07 2021	SELL Open market or private sale	$62,945 $251.78 p/Share	250 Reduced 5.37%	4,409 Common Stock
Feb 08 2021	SELL Open market or private sale	$59,498 $237.99 p/Share	250 Reduced 5.09%	4,659 Common Stock
Nov 09 2020	SELL Open market or private sale	$60,600 $242.4 p/Share	250 Reduced 4.85%	4,909 Common Stock
Aug 07 2020	SELL Open market or private sale	$60,737 $242.95 p/Share	250 Reduced 4.62%	5,159 Common Stock
May 06 2020	SELL Open market or private sale	$100,857 $237.31 p/Share	425 Reduced 7.28%	5,409 Common Stock
May 05 2020	BUY Grant, award, or other acquisition	-	846 Added 12.66%	5,834 Common Stock
Feb 06 2020	SELL Open market or private sale	$99,331 $233.72 p/Share	425 Reduced 7.85%	4,988 Common Stock
Nov 06 2019	SELL Open market or private sale	$91,566 $215.45 p/Share	425 Reduced 7.28%	5,413 Common Stock
Aug 07 2019	SELL Open market or private sale	$77,792 $183.04 p/Share	425 Reduced 6.79%	5,838 Common Stock
May 03 2019	BUY Grant, award, or other acquisition	-	1,127 Added 15.25%	6,263 Common Stock
Apr 27 2018	BUY Grant, award, or other acquisition	-	1,127 Added 17.99%	5,136 Common Stock
May 01 2017	BUY Grant, award, or other acquisition	-	1,230 Added 23.48%	4,009 Common Stock
May 03 2016	BUY Grant, award, or other acquisition	-	1,279 Added 31.52%	2,779 Common Stock
Apr 24 2015	BUY Grant, award, or other acquisition	-	1,191 Added 44.26%	1,500 Common Stock
Oct 30 2014	BUY Grant, award, or other acquisition	-	309 Added 50.0%	309 Common Stock

Also insider at

LABORATORY CORP OF AMERICA HOLDINGS Healthcare

Director

TNYA

Tenaya Therapeutics, Inc. Healthcare

RSW